bupranolol has been researched along with Tachycardia in 3 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " (-)-Bupranolol and compounds (-)-GD-6, (+)-GD-6, (-)-DZ-13, (+)-DZ-13, DZ-51 and DZ-52 antagonized the CGP 12177-induced tachycardia in pithed rats with "apparent pA(2) values" of 6." | 3.75 | Four close bupranolol analogues are antagonists at the low-affinity state of beta1-adrenoceptors. ( Baranowska, M; Baranowska, U; Kiec-Kononowicz, K; Kozlowska, H; Malinowska, B; Reutelsterz, A; Schlicker, E; Zelaszczyk, D, 2009) |
| "Bupranolol is a promising candidate for transdermal drug delivery system (TDDS) development." | 1.35 | Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers. ( Babu, RJ; Dhanasekaran, M; Pandit, JK; Singh, PN; Vaithiyalingam, SR, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zelaszczyk, D | 1 |
| Kozlowska, H | 1 |
| Baranowska, U | 1 |
| Baranowska, M | 1 |
| Reutelsterz, A | 1 |
| Kiec-Kononowicz, K | 1 |
| Malinowska, B | 1 |
| Schlicker, E | 1 |
| Babu, RJ | 1 |
| Dhanasekaran, M | 1 |
| Vaithiyalingam, SR | 1 |
| Singh, PN | 1 |
| Pandit, JK | 1 |
| Marsala, F | 1 |
1 trial available for bupranolol and Tachycardia
| Article | Year |
|---|---|
[Therapy of hyperdynamic disorders of the cardio-circulatory system with bupranolol chlorhydrate].
Topics: Adolescent; Adult; Aged; Blood Pressure; Bupranolol; Clinical Trials as Topic; Female; Heart Rate; H | 1983 |
2 other studies available for bupranolol and Tachycardia
| Article | Year |
|---|---|
Four close bupranolol analogues are antagonists at the low-affinity state of beta1-adrenoceptors.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Buprano | 2009 |
Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Animals; Area Under Curve; beta-Cyclodextrin | 2008 |